The failed PHOENIX study was the confirmatory trial for Relyvrio, which was approved based on the smaller, successful CENTAUR study. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
